Hot Topics

Poll

Why is it a big mistake to link funding of R&D costs with drug prices?:

World Health Organization (WHO) to hold consultation on report of Expert Working Group on R&D financing

At the end of a dramatic debate that began yesterday, the Executive Board (EB) of the World Health Organization (WHO) agreed to hold a special consultation on the report of the WHO Expert Working Group (EWG) on R&D Financing. A face-to-face meeting will be held on May 13, a few days before the 63rd WHA begins on 17 May. There will also be opportunities for web submissions on the EWG report. In addition, Dr.

Brazilian statement to EB 126 (Jan 2010) on public health, innovation and intellectual property

On Monday, 18 January 2010, Brazil delivered the following statement to the 126th session of the Executive Board of the World Health Organization (WHO) under agenda item 4.3 "public health, innovation and intellectual property". In her intervention, the delegate of Brazil stressed,

Corporate sponsors of the George Institute

As the 126th session of the Executive Board (EB) of the World Health Organization unfolds today, it appears that the EB will consider agenda item 4.3 on Public health, innovation and intellectual property: Global strategy and plan of action. Under scrutiny will be the work of the Expert Working Group on research and development financing which is mandated by resolution WHA61.21

Open Letter to the WHO EB from Cecilia López Montaño, EWG member

The following is a letter sent by Cecilia López Montaño, a member of the WHO Expert Working Group on R&D Financing to the WHO Executive Board:

Bogotá. Colombia. January 15th 2010

Dear members of the Executive Board:

I am Cecilia López Montaño, senator of the Colombian Congress and member of the Expert Working Group on Research and Development Financing of the World Health Organization, in representation of the point of view of developing countries, I assume.

Final Report of the WHO Expert Working on R&D Financing published on Friday, January 15, 2010

At the proverbial 11th hour today, the World Health Organization published the final report of the "World Health Organization Expert Working Group on Research and Development Financing" in English three days before the commencement of the 126th session of the WHO Executive Board on January 18, 2010. At this juncture, it does not appear that the WHO Secretariat has made available official versions of this Report in Arabic, Chinese, French, Russian and Spanish for Member States' consideration.

A closer look at the WHO EWG endorsed proposals on funding product development partnerships

The World Health Organization's Expert Working Group on R&D Financing spent scant attention on how to raise money, but showed considerable interest in how to spend it. The clear favorite approach is to give grants to product development partnerships -- the approach that has now become the most conventional approach, and one not surprisingly endorsed by the PDPs themselves, and also by the Gates Foundation and the IFPMA -- two groups that are often seen as devoted to protecting the status quo in terms of intellectual property and business models for innovation.

The baffling WHO EWG analysis of innovation inducement prizes

The World Health Organization (WHO) Executive Board will soon consider the Executive Summary of the Report of the Expert Working Group on Research and Development Financing, a document, formally identified as EB 126/6 Add.1.

In the section of the report on "Funding allocation proposals," the EWG considers two types of innovation inducement prizes, including

31 (c) milestone prizes; and
31 (d) end-prizes (cash)

The WHO EWG's proposals for taxes to fund medical R&D

Some surprising taxes, and evidence of IFPMA lobbying

Video of Google, DC January 11, 2010 debate on ACTA

On January 11, 2010, the Washington office of Google hosted a deb

New WHO documents published in relation to 3rd EWG meeting

New documents have been published on the WHO website in relation to the third meeting of the WHO Expert Working Group on R&D Financing that took place from November 30 to December 2, 2009. These six documents are available at:

http://www.who.int/phi/ewg3rdmeet/en/index.html

The first document is: Comparative Review of Innovative Financing Proposals for Health R&D

The second document is: Coordinating Arrangements for R&D [doc 352kb]

USTR's new hearings on 301 list

USTR has issued an announcement for new procedures including public hearings on the 2010 Special 301 list. This is an effort to make the 301 process somewhat more open, and to provide more formal opportunities to both supporters and critics of USTR's bilateral trade pressures to make their case. USTR's actions are welcomed by several NGOs that have been critical of the unilateral trade pressures initiative, as it seems to provide the beginning of a more mature discussion about the objectives of trade policy, and the evidence to support different positions.

Senator Wyden's letter to the USTR on ACTA

Senator Wyden has written to the USTR posing 11 questions aiming to clarify the specific objectives of the Anti Counterfeiting Trade Agreement (ACTA). The next round of negotiations are scheduled to take place in Mexico during the week of January 25. The letter is available here.

Key dates for WIPO negotiations in 2010

On December 21, 2009, WIPO sent out a circular note (C.N 3066) indicating "provisional dates for the principal committees and bodies of the World Intellectual Property Organization (WIPO) that will meet in 2010".

Here are provisional dates of key negotiations to bear in mind when planning your agenda for 2010.

SCP
WIPO Standing Committee on the Law of Patents, SCP, (14th session): January 25-29, 2010.

WIPO Standing Committee on the Law of Patents, SCP, (15th session): October 11-15, 2010

SCCR

Official executive summary of the report of the WHO Expert Working Group on Research and Development Financing

23 December 2009

The Official Executive Summary and Recommendations of the Report of the Expert Working Group on Research and Development Financing to the Executive Board has been published on the website of the WHO Executive Board as document EB126/6 Add.1. It has a provisional agenda item number of 4.3. The official WHO link to this Executive Summary is: http://apps.who.int/gb/ebwha/pdf_files/EB126/B126_6Add1-en.pdf

Syndicate content